Workflow
GSI Technology(GSIT) - 2025 Q3 - Quarterly Report
GSITGSI Technology(GSIT)2025-02-10 21:05

Financial Performance - Net revenues increased by 1.8% from 5.3millioninQ32023to5.3 million in Q3 2023 to 5.4 million in Q3 2024, but decreased by 11.9% from 16.6millionintheninemonthsendedDecember31,2023to16.6 million in the nine months ended December 31, 2023 to 14.6 million in the same period in 2024[113]. - Gross profit decreased by 1.8% from 3.0millioninQ32023to3.0 million in Q3 2023 to 2.9 million in Q3 2024, and by 25.4% from 9.2millionintheninemonthsendedDecember31,2023to9.2 million in the nine months ended December 31, 2023 to 6.8 million in the same period in 2024[117]. - Net loss was 6.6millioninQ32023comparedto6.6 million in Q3 2023 compared to 4.0 million in Q3 2024, and 15.8millionintheninemonthsendedDecember31,2023comparedto15.8 million in the nine months ended December 31, 2023 compared to 8.4 million in the same period in 2024[124]. Revenue Sources - Revenue is primarily generated from Very Fast SRAM products, with direct and indirect sales to networking and telecommunications OEMs accounting for 32% to 49% of net revenues over the last three fiscal years[100]. - Nokia was the largest end user customer, representing approximately 14% of net revenues in the nine months ended December 31, 2024, down from 29% in fiscal 2022[105]. Cash and Cash Equivalents - The company reported cash and cash equivalents of 15.1millionasofDecember31,2024,withnodebt[98].CashandcashequivalentsasofDecember31,2024were15.1 million as of December 31, 2024, with no debt[98]. - Cash and cash equivalents as of December 31, 2024 were 15.1 million, up from 14.4millionasofMarch31,2024[125].Thecompanyhascashandcashequivalentstotaling14.4 million as of March 31, 2024[125]. - The company has cash and cash equivalents totaling 15.1 million as of December 31, 2024, primarily invested in money market funds for working capital purposes[140]. Operating Expenses - Operating expenses were reduced by approximately 3.5milliononanannualizedbasis,resultingina163.5 million on an annualized basis, resulting in a 16% decrease in the global workforce[99]. - Selling, general and administrative expenses increased by 11.7% from 2.7 million in Q3 2023 to 3.0millioninQ32024[120].Researchanddevelopmentexpensesdecreasedby42.13.0 million in Q3 2024[120]. - Research and development expenses decreased by 42.1% from 7.0 million in Q3 2023 to 4.0millioninQ32024,primarilyduetoadecreaseinpreproductionmaskcosts[118].FutureOutlookThecompanyanticipatescontinuedinflationarypressuresandgeopoliticaltensionswillnegativelyimpactfinancialperformanceinfiscal2025andbeyond[98].Thecompanyhasexperiencedincreasedcostsduetoinflationandsupplychainconstraints,affectingthecostofrevenues[106].Futurecapitalrequirementswilldependonfactorssuchasrevenuegrowth,manufacturingcostincreases,andspendingtosupportproductdevelopmentandsalesexpansion[131].Thecompanymayrequireadditionalcapitalforpotentialacquisitionsofbusinesses,products,ortechnologies[131].ContractsandAgreementsThecompanyexpectstoreceivemilestonepaymentstotalinganestimated4.0 million in Q3 2024, primarily due to a decrease in pre-production mask costs[118]. Future Outlook - The company anticipates continued inflationary pressures and geopolitical tensions will negatively impact financial performance in fiscal 2025 and beyond[98]. - The company has experienced increased costs due to inflation and supply chain constraints, affecting the cost of revenues[106]. - Future capital requirements will depend on factors such as revenue growth, manufacturing cost increases, and spending to support product development and sales expansion[131]. - The company may require additional capital for potential acquisitions of businesses, products, or technologies[131]. Contracts and Agreements - The company expects to receive milestone payments totaling an estimated 1.25 million under a prototype agreement with the Space Development Agency for the development of APU2[95]. - The company received payments of 124,000and124,000 and 157,000 under two separate contracts during the nine months ended December 31, 2024[95][97]. Financial Activities - Net cash used in operating activities was 11.3millionfortheninemonthsendedDecember31,2024,comparedto11.3 million for the nine months ended December 31, 2024, compared to 10.2 million for the same period in 2023[126]. - Net cash provided by investing activities was 11.4millionintheninemonthsendedDecember31,2024,comparedto11.4 million in the nine months ended December 31, 2024, compared to 2.8 million in the same period in 2023[129]. - Net cash provided by financing activities in the nine months ended December 31, 2024 was 622,000,downfrom622,000, down from 1.6 million in the same period in 2023[130]. Accounting and Risk Management - The company completed its annual goodwill impairment test with no impairment noted, maintaining a goodwill balance of $8.0 million[111]. - The company has no off-balance sheet arrangements or relationships with unconsolidated entities, mitigating exposure to financing, liquidity, market, or credit risk[136]. - The company does not currently enter into forward exchange contracts to hedge foreign currency exposure, which is minimal due to most revenues and expenses being denominated in U.S. dollars[139]. - A hypothetical 100 basis point change in interest rates is not expected to materially affect the fair value of the company's interest-sensitive financial instruments[140]. - The company has disclosed critical accounting estimates in its Annual Report on Form 10-K for the fiscal year ended March 31, 2024[134].